DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Core Insights - DaVita faced notable challenges in 2025, including a tough flu season in Q1 and a significant cyber incident in Q2 [2] - Despite these challenges, DaVita managed to maintain its guidance and continue delivering operating results [3] Group 1: Challenges Faced - The primary challenges for DaVita were related to volume, which is a key metric for the company and investors [3] - Revenue per treatment also posed challenges during the year [3] Group 2: Company Performance - DaVita's management effectively handled the cyber incident, showcasing the company's operational resilience [2] - The company is focused on navigating through the challenges while ensuring operational performance remains strong [3]